BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Hepatic steatosis
1
Gluten’s silent strike: Unmasking its impact on liver health
12/22/2025 7:43:02 AM | Browse: 17 | Download: 78
2
Fatty liver reexamined choline and mitochondrial toxin amelioration
12/4/2025 6:40:47 AM | Browse: 32 | Download: 88
3
Machine learning to predict metabolic-associated fatty liver disease
12/3/2025 9:10:07 AM | Browse: 34 | Download: 116
4
Bile acids in metabolic dysfunction-associated steatotic liver disease
8/27/2025 9:21:12 AM | Browse: 156 | Download: 282
5
Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease
8/27/2025 9:21:11 AM | Browse: 142 | Download: 293
6
Copper and hepatic lipid dysregulation: Mechanisms and implications
8/27/2025 9:21:08 AM | Browse: 71 | Download: 166
7
Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease
7/24/2025 7:47:21 AM | Browse: 53 | Download: 119
8
Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk
7/21/2025 9:42:33 AM | Browse: 49 | Download: 241
9
Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence
6/12/2025 3:45:50 AM | Browse: 61 | Download: 393
10
Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation
4/29/2025 9:13:41 AM | Browse: 71 | Download: 431
11
Correlation of liver imaging and transient elastography among patients with hepatitis C at a safety net hospital
4/25/2025 8:23:05 AM | Browse: 100 | Download: 458
12
Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease
2/14/2025 10:33:16 AM | Browse: 106 | Download: 480
13
Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy via activation of the AMPK signaling pathway
1/20/2025 7:38:46 AM | Browse: 59 | Download: 440
14
Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
10/21/2024 7:03:24 AM | Browse: 146 | Download: 544
15
Hepatoprotective effects of Xiaoyao San formula on hepatic steatosis and inflammation via regulating the sex hormones metabolism
7/26/2024 10:33:30 AM | Browse: 161 | Download: 968
16
Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease
5/22/2024 11:33:24 AM | Browse: 83 | Download: 490
17
Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis
10/24/2023 7:40:57 AM | Browse: 244 | Download: 849
18
Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas
7/10/2023 8:58:21 AM | Browse: 434 | Download: 1121
19
Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications
5/7/2023 7:47:34 AM | Browse: 394 | Download: 1099
20
Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact
1/12/2023 10:19:09 AM | Browse: 423 | Download: 1321
21
Hepatic steatosis with mass effect: A case report
10/21/2022 2:24:59 AM | Browse: 594 | Download: 2049
22
Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations
10/18/2022 8:29:59 AM | Browse: 663 | Download: 1350
23
Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
9/13/2022 3:28:02 AM | Browse: 740 | Download: 1685
24
Nonalcoholic fatty liver disease and diabetes
9/9/2022 3:45:24 PM | Browse: 694 | Download: 1639
25
Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
8/26/2022 9:51:35 AM | Browse: 599 | Download: 1325
26
Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
4/30/2022 5:08:22 AM | Browse: 629 | Download: 1874
27
Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations
4/22/2022 10:52:23 AM | Browse: 645 | Download: 1588
28
Hepatobiliary manifestations in inflammatory bowel disease: A practical approach
2/22/2022 9:25:37 AM | Browse: 476 | Download: 1161
29
Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus
9/10/2021 7:23:16 AM | Browse: 571 | Download: 1881
30
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond
4/29/2021 2:12:02 AM | Browse: 641 | Download: 1565
31
Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases
12/30/2020 1:59:10 PM | Browse: 764 | Download: 2215
32
MANF ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism
3/14/2020 3:03:29 PM | Browse: 1026 | Download: 2265
33
Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways
9/12/2019 8:50:34 AM | Browse: 861 | Download: 2487
34
Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents
3/28/2019 9:14:41 AM | Browse: 1226 | Download: 2576
35
Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway
3/28/2019 9:14:40 AM | Browse: 1082 | Download: 2152
36
Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice
3/20/2019 5:32:10 AM | Browse: 1095 | Download: 2431
37
Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease
1/26/2018 8:09:36 AM | Browse: 980 | Download: 2078
38
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12/20/2017 2:49:19 AM | Browse: 1634 | Download: 2134
39
Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
8/14/2017 1:56:00 AM | Browse: 1284 | Download: 2305
40
S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis
8/10/2017 11:54:13 PM | Browse: 1493 | Download: 2607
41
Is hepatic steatosis associated with left ventricular mass index increase in the general population?
7/5/2017 4:40:08 AM | Browse: 1143 | Download: 2701
42
Antioxidant dietary approach in treatment of fatty liver: New insights and updates
6/20/2017 12:12:52 PM | Browse: 1345 | Download: 2524
43
Embrionary way to create a fatty liver in portal hypertension
5/16/2017 6:56:36 AM | Browse: 1483 | Download: 3031
44
Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver
3/13/2017 1:20:00 PM | Browse: 1381 | Download: 2030
45
Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial
1/5/2017 11:10:00 AM | Browse: 1764 | Download: 3611
46
Quality of life 10 years after liver transplantation: The impact of graft histology
12/14/2016 2:15:00 PM | Browse: 1256 | Download: 1773
47
Hepatic steatosis and fibrosis: Non-invasive assessment
12/6/2016 5:24:00 PM | Browse: 1373 | Download: 1933
48
Retrospective study of the associations between hepatitis C virus infection and metabolic factors
10/25/2016 8:46:00 AM | Browse: 1781 | Download: 2952
49
Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-Ⅰ dysfunction
5/19/2016 9:54:00 AM | Browse: 1237 | Download: 2831
50
Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality
12/24/2015 11:11:00 AM | Browse: 1272 | Download: 2111
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345